2.11. Primary and Secondary Endpoints
obesity, overweight, weight loss
OBESITY, BLOOD, SECONDARY, INSULIN RESISTANCE
The primary endpoint was to evaluate the effect of the intake of PG on weight loss in a group of subjects suffering from overweight and mild obesity (BMI between 25 and 32), and with a weight > 75 kg.The secondary endpoints were to evaluate the effect of PG supplementation on blood levels of triglycerides, TC, HDL-C, LDL-C, glucose, insulin, insulin resistance, liver enzymes (transaminases), creatinine, waist circumference, body composition, serum levels of reactive oxygen species, and the serum antioxidant capacity. Blood levels of fat-soluble vitamins A, D